The National Hepatitis Corrections Network (NHCN) and the National Viral Hepatitis Roundtable (NVHR) are hosting a virtual subject matter expert panel and Q&A about the use of 340B in correctional institutions. The event is designed to provide information to correctional entities who are interested in utilizing the 340B drug pricing program to improve viral hepatitis treatment in their facilities.
The webinar content will include an overview of what 340B is and is not, key considerations for use of 340B in correctional health entities, and a panel of subject-matter experts who will offer technical assistance, share their experiences, and provide insight into what people can expect when employing 340B in correctional facilities. Register here.
Brandon Sis – Senior Pharmacist for Corrections, Minnesota Multistate Contracting Alliance for Pharmacy
Emily McCloskey – Director Policy and Legislative Affairs, NASTAD
Jeff Davis – Senior Advisor of Counsel, Baker Donelson
Pauline Marcussen – Healthcare Services Administrator, Rhode Island Department of Corrections Robert Lawrence – Chief Medical Officer, Alaska Department of Corrections